STOCK TITAN

[Form 4] Ventas, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Ventas (VTR) director Matthew J. Lustig reported routine acquisitions of common stock units on October 16, 2025 from dividend equivalents credited under director deferral programs. He received 250.738 units under the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 units under the Non-Employee Directors' Equity Award Deferral Program, each valued at the closing price of $69.55 per share as of the grant date. After these credits, he directly beneficially owned 91,546.943 shares.

Vendite (VTR) Il direttore Matthew J. Lustig ha riferito acquisizioni ordinarie di unità azionarie comuni il 16 ottobre 2025 da equivalenti di dividendo accreditati ai sensi dei programmi di differimento per i membri del consiglio. Ha ricevuto 250.738 unità ai sensi del Non-Employee Directors' Cash Compensation Deferral Plan e 74.76 unità ai sensi del Non-Employee Directors' Equity Award Deferral Program, ognuna valutata al prezzo di chiusura di $69.55 per azione al momento dell'assegnazione. Dopo tali accrediti, detiene direttamente e beneficiariamente 91,546.943 azioni.

Ventas (VTR) el director Matthew J. Lustig informó adquisiciones habituales de unidades de acciones comunes el 16 de octubre de 2025 provenientes de equivalentes de dividendos acreditados bajo los programas de diferimiento para directores. Recibió 250.738 unidades bajo el Non-Employee Directors' Cash Compensation Deferral Plan y 74.76 unidades bajo el Non-Employee Directors' Equity Award Deferral Program, cada una valorada al precio de cierre de $69.55 por acción en la fecha de la concesión. Después de estos créditos, poseía directa y beneficiosamente 91,546.943 acciones.

매수( VTR ) 이사 Matthew J. Lustig은 2025년 10월 16일에 이사 연기 프로그램 아래에서 배당금 등가액으로 적립된 일반 주식 단위의 정기 취득을 보고했습니다. 그는 Non-Employee Directors' Cash Compensation Deferral Plan에 따라 250.738단위, Non-Employee Directors' Equity Award Deferral Program에 따라 74.76단위를 받았으며, 각각 발행일의 종가 $69.55를 기준으로 평가되었습니다. 이 크레딧 이후 그는 직접적으로 유익하게 91,546.943주를 소유하게 되었습니다.

Ventes (VTR) le directeur Matthew J. Lustig a signalé des acquisitions ordinaires d’unités d’actions ordinaires le 16 octobre 2025 provenant d’équivalents de dividendes crédités dans le cadre des programmes de report pour les administrateurs. Il a reçu 250.738 unités dans le cadre du Non-Employee Directors' Cash Compensation Deferral Plan et 74.76 unités dans le cadre du Non-Employee Directors' Equity Award Deferral Program, chacune évaluée à le prix de clôture de $69.55 par action à la date d’attribution. Après ces crédits, il détenait directement et bénéficiait de 91,546.943 actions.

Verkäufe (VTR) Der Direktor Matthew J. Lustig berichtete von routinemäßigen Käufen gewöhnlicher Aktieneinheiten am 16. Oktober 2025 durch Dividendenäquivalente, gutgeschrieben im Rahmen der Direktoren-Verzögerungsprogramme. Er erhielt 250.738 Einheiten im Rahmen des Non-Employee Directors' Cash Compensation Deferral Plan und 74.76 Einheiten im Rahmen des Non-Employee Directors' Equity Award Deferral Program, jeweils bewertet zum Schlusskurs von $69.55 pro Aktie zum Zeitpunkt der Gewährung. Nach diesen Gutschriften besaß er direkt vorteilhaft 91.546.943 Aktien.

المبيعات (VTR) أبلغ المدير ماثيو ج. لوستيغ عن عمليات شراء روتينية للوحدات العادية من الأسهم في 16 أكتوبر 2025 من البدائل الموزعة للأرباح المعتمدة ضمن برامج تأجيل للمسؤولين. تلقّى 250.738 وحدة بموجب خطة تأجيل تعويض النقد لمديري غير الموظفين و 74.76 وحدة بموجب برنامج تأجيل منح الأسهم لمديري غير الموظفين، وكل وحدة مُقَدَّرة بسعر الإغلاق $69.55 لكل سهم في تاريخ المنح. بعد هذه الاعتمادات، أصبح يملك مباشرة وبمنفعة كاملة 91,546.943 سهمًا.

销售 (VTR) 董事 Matthew J. Lustig 报告称在 2025年10月16日,从股息等同额在董事延期计划下记入的常规普通股单位的购买。他在 Non-Employee Directors' Cash Compensation Deferral Plan 下获得 250.738 单位,在 Non-Employee Directors' Equity Award Deferral Program 下获得 74.76 单位,每单位按授予日的收盘价 $69.55 计价。完成这些记入后,他直接受益拥有 91,546.943 股。

Positive
  • None.
Negative
  • None.

Vendite (VTR) Il direttore Matthew J. Lustig ha riferito acquisizioni ordinarie di unità azionarie comuni il 16 ottobre 2025 da equivalenti di dividendo accreditati ai sensi dei programmi di differimento per i membri del consiglio. Ha ricevuto 250.738 unità ai sensi del Non-Employee Directors' Cash Compensation Deferral Plan e 74.76 unità ai sensi del Non-Employee Directors' Equity Award Deferral Program, ognuna valutata al prezzo di chiusura di $69.55 per azione al momento dell'assegnazione. Dopo tali accrediti, detiene direttamente e beneficiariamente 91,546.943 azioni.

Ventas (VTR) el director Matthew J. Lustig informó adquisiciones habituales de unidades de acciones comunes el 16 de octubre de 2025 provenientes de equivalentes de dividendos acreditados bajo los programas de diferimiento para directores. Recibió 250.738 unidades bajo el Non-Employee Directors' Cash Compensation Deferral Plan y 74.76 unidades bajo el Non-Employee Directors' Equity Award Deferral Program, cada una valorada al precio de cierre de $69.55 por acción en la fecha de la concesión. Después de estos créditos, poseía directa y beneficiosamente 91,546.943 acciones.

매수( VTR ) 이사 Matthew J. Lustig은 2025년 10월 16일에 이사 연기 프로그램 아래에서 배당금 등가액으로 적립된 일반 주식 단위의 정기 취득을 보고했습니다. 그는 Non-Employee Directors' Cash Compensation Deferral Plan에 따라 250.738단위, Non-Employee Directors' Equity Award Deferral Program에 따라 74.76단위를 받았으며, 각각 발행일의 종가 $69.55를 기준으로 평가되었습니다. 이 크레딧 이후 그는 직접적으로 유익하게 91,546.943주를 소유하게 되었습니다.

Ventes (VTR) le directeur Matthew J. Lustig a signalé des acquisitions ordinaires d’unités d’actions ordinaires le 16 octobre 2025 provenant d’équivalents de dividendes crédités dans le cadre des programmes de report pour les administrateurs. Il a reçu 250.738 unités dans le cadre du Non-Employee Directors' Cash Compensation Deferral Plan et 74.76 unités dans le cadre du Non-Employee Directors' Equity Award Deferral Program, chacune évaluée à le prix de clôture de $69.55 par action à la date d’attribution. Après ces crédits, il détenait directement et bénéficiait de 91,546.943 actions.

Verkäufe (VTR) Der Direktor Matthew J. Lustig berichtete von routinemäßigen Käufen gewöhnlicher Aktieneinheiten am 16. Oktober 2025 durch Dividendenäquivalente, gutgeschrieben im Rahmen der Direktoren-Verzögerungsprogramme. Er erhielt 250.738 Einheiten im Rahmen des Non-Employee Directors' Cash Compensation Deferral Plan und 74.76 Einheiten im Rahmen des Non-Employee Directors' Equity Award Deferral Program, jeweils bewertet zum Schlusskurs von $69.55 pro Aktie zum Zeitpunkt der Gewährung. Nach diesen Gutschriften besaß er direkt vorteilhaft 91.546.943 Aktien.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LUSTIG MATTHEW J

(Last) (First) (Middle)
C/O VENTAS, INC.
300 NORTH LASALLE ST., SUITE 1600

(Street)
CHICAGO IL 60654

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ventas, Inc. [ VTR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/16/2025 A 250.738(1) A $69.55(2) 91,472.183 D
Common Stock 10/16/2025 A 74.76(3) A $69.55(2) 91,546.943 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.
2. Represents the closing price per share of Issuer's common stock as of the grant date.
3. Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.
Remarks:
Matthew J. Lustig, By: /s/ Jessica Stricklin, Attorney-In-Fact 10/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Ventas

NYSE:VTR

VTR Rankings

VTR Latest News

VTR Latest SEC Filings

VTR Stock Data

31.61B
451.87M
0.57%
101.82%
3.41%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
CHICAGO